| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/27/2011 | CA2377519C Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies |
| 09/27/2011 | CA2336218C Neurotrophic factors |
| 09/27/2011 | CA2283058C Procedure for simultaneous determination of hiv antigens and hiv antibodies |
| 09/27/2011 | CA2279476C Novel antibody composition for isolating human cells from human-murine chimeric hematopoietic cell suspensions |
| 09/27/2011 | CA2278585C A method for in vitro molecular evolution of protein function |
| 09/27/2011 | CA2213331C Chemokine receptors 88-2b [ckr-3] and 88c and their antibodies |
| 09/22/2011 | WO2011116226A2 Display of antibody fragments on virus-like particles of rna bacteriophages |
| 09/22/2011 | WO2011116209A2 Using phage epitopes to profile the immune response |
| 09/22/2011 | WO2011116090A1 Anti-nerve growth factor (ngf) antibody compositions |
| 09/22/2011 | WO2011116014A2 Humanized antibodies to labyrinthin and uses thereof |
| 09/22/2011 | WO2011115483A1 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 09/22/2011 | WO2011115271A1 Tumor angiogenesis inhibitor |
| 09/22/2011 | WO2011115231A1 Osteopontin specific monoclonal antibody |
| 09/22/2011 | WO2011115225A1 Periodontal-disease-specific peptide, and treatment and diagnosis of periodontal disease using same |
| 09/22/2011 | WO2011114353A1 Monovalent human anti-hepatitis a virus antibody and uses thereof |
| 09/22/2011 | WO2011113869A1 Canine astrovirus astv strain bari/08 identified in dogs with gastro-enteritis |
| 09/22/2011 | WO2011113604A1 Peptides or antibodies which bind to melanoma inhibitory activity (mia) protein |
| 09/22/2011 | WO2011094465A4 Methods of treating autoimmune diseases with dll4 antagonists |
| 09/22/2011 | WO2011088288A8 Hybridoma cell lines and monoclonal antibodies recognizing anthrose saccharide of bacillus anthracis |
| 09/22/2011 | WO2011083141A3 Panning phage libraries with lipoprotein particles expressing the target antigen |
| 09/22/2011 | WO2011063237A3 Jagged-binding agents and uses thereof |
| 09/22/2011 | WO2011031833A3 Human anti-cancer antibodies |
| 09/22/2011 | US20110231952 Soybean nodulation factor receptor proteins, encoding nucleic acids and uses therefor |
| 09/22/2011 | US20110231942 Tiki1 and tiki2, wnt inhibitors |
| 09/22/2011 | US20110230649 Compositions and Methods for Redox Modulated Proteins |
| 09/22/2011 | US20110230647 Compositions and methods for modulating lymphocyte activity |
| 09/22/2011 | US20110230646 Hybrid antibodies |
| 09/22/2011 | US20110230637 Modified human thymic stromal lymphopoietin |
| 09/22/2011 | US20110230392 Novel narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, and narc 25 molecules and uses therefor |
| 09/22/2011 | US20110230365 Mutations Associated With Cystic Fibrosis |
| 09/22/2011 | US20110229984 Materials and methods directed to asparagine synthetase and asparaginase therapies |
| 09/22/2011 | US20110229979 Risperidone immunoassay |
| 09/22/2011 | US20110229912 Anti-preproprotein and anti-preprotein antibodies as immunohistochemical markers |
| 09/22/2011 | US20110229909 RHO1-Gamma Amino Butyric Acid C Receptor-Specific Antibodies |
| 09/22/2011 | US20110229908 Methods and products for measuring free immunoglobulin light chain molecules |
| 09/22/2011 | US20110229905 Compositions and methods for diagnosing and treating cancer and neurodegenerative diseases rlated to beclin-1 |
| 09/22/2011 | US20110229895 Method for diagnosing polycystic kidney disease |
| 09/22/2011 | US20110229892 Method for predicting a patient's responsiveness to anti-folate therapy |
| 09/22/2011 | US20110229891 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation |
| 09/22/2011 | US20110229505 Methods for the diagnosis and treatment of cancer based on AVL9 |
| 09/22/2011 | US20110229489 Antibodies with pH Dependent Antigen Binding |
| 09/22/2011 | US20110229487 Therapeutic agent comprising antibody capable of specifically binding to human hmgb-1 as active ingredient |
| 09/22/2011 | US20110229486 Monoclonal Antibodies Against NKG2A |
| 09/22/2011 | US20110229485 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
| 09/22/2011 | US20110229482 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood by preventing viral entry into a cell |
| 09/22/2011 | US20110229481 Cancer-associated antigen analogue peptides and uses thereof |
| 09/22/2011 | US20110229480 Pta072 protein |
| 09/22/2011 | US20110229479 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma |
| 09/22/2011 | US20110229478 Erbb3 based methods and compositions for treating neoplasms |
| 09/22/2011 | US20110229477 Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy |
| 09/22/2011 | US20110229476 Monospecific and multispecific antibodies and method of use |
| 09/22/2011 | US20110229475 Novel compounds |
| 09/22/2011 | US20110229473 Methods for using taci-immunoglobulin fusion proteins |
| 09/22/2011 | US20110229466 Vascular endothelial growth factor 2 |
| 09/22/2011 | US20110229463 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 09/22/2011 | US20110229461 PD-1 Antibodies |
| 09/22/2011 | US20110229459 Anti-nr10 antibody and use thereof |
| 09/22/2011 | US20110229458 Methods for selecting protease resistant polypeptides |
| 09/22/2011 | US20110229434 Uses of mammalian cytokine; related reagents |
| 09/22/2011 | US20110229415 Semi-synthetic antibodies as recognition elements |
| 09/22/2011 | US20110229407 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof |
| 09/22/2011 | CA2793309A1 Method of producing transcripts using cryptic splice sites |
| 09/22/2011 | CA2793087A1 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
| 09/22/2011 | CA2790699A1 Anti-nerve growth factor (ngf) antibody compositions |
| 09/22/2011 | CA2790408A1 Risperidone immunoassay |
| 09/21/2011 | EP2366718A2 Ligand |
| 09/21/2011 | EP2366717A2 Combination Cancer Immunotherapy with Co-Stimulatory Molecules |
| 09/21/2011 | EP2366716A2 Combinatorial therapy involving alpha5beta1 antagonists |
| 09/21/2011 | EP2366715A2 Rankl Antibody-PTH/PTHRP Chimeric Molecules |
| 09/21/2011 | EP2366714A1 Naturally occuring autoantibodies against alpha-synuclein that inhibit the aggregation and cytotoxicity of alpha-synuclein |
| 09/21/2011 | EP2366713A2 Polypeptide variants with altered effector function |
| 09/21/2011 | EP2366712A2 A tumor suppressor designated TS10Q23.3 |
| 09/21/2011 | EP2366711A2 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
| 09/21/2011 | EP2366708A1 Canine astrovirus AstV strain Bari/08 identified in dogs with gastro-enteritis |
| 09/21/2011 | EP2366706A1 Regeneration of endogenous myocardial tissue by induction of neovascularization |
| 09/21/2011 | EP2366405A2 IL-17 antagonistic antibodies |
| 09/21/2011 | EP2365987A1 Isoform specific anti-her4 antibodies |
| 09/21/2011 | EP2365986A1 Deglycosylated antibodies |
| 09/21/2011 | EP2365956A2 Long acting conserved natural functional groups curcumin |
| 09/21/2011 | EP2365828A2 Monoclonal antibodies to fibroblast growth factor receptor 2 |
| 09/21/2011 | EP2365827A1 Fully human influenza m2 specific antibodies |
| 09/21/2011 | EP1888636B1 Method for the purification of antibodies |
| 09/21/2011 | EP1654358B1 Binding constructs and methods for use thereof |
| 09/21/2011 | EP1597282B1 Antibody molecules having specificity for human il-1 beta |
| 09/21/2011 | EP1565493B1 Antibody for the thyrotropin receptor and uses thereof |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1399556B1 Antigenic epitopes of factor viii, inhibitors directed against said epitopes and use thereof |
| 09/21/2011 | EP1385993B8 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 09/21/2011 | EP1334178B1 Slo2 and slo4, novel potassium channel proteins from human brain |
| 09/21/2011 | EP1073905B1 Methods of selecting internalizing antibodies |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | CN1927883B Novel cytokine zalpha11 ligand |
| 09/21/2011 | CN1898266B Removal of high molecular weight aggregates using hydroxyapatite chromatography |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN102197052A High affinity human antibodies to human IL-4 receptor |
| 09/21/2011 | CN102197051A Uses of IL-22, IL-17, and IL-1 family cytokines in autoimmune diseases |
| 09/21/2011 | CN102197050A Hepatitis c antibodies and uses thereof |
| 09/21/2011 | CN102191319A Oligonucleotide probes, for use in assessing gene transcript levels in a cell |
| 09/21/2011 | CN102191226A Separation and purification method for cell culture mixture |